Skip to main content
. 2020 Jan 15;10:321. doi: 10.1038/s41598-019-56947-1

Table 2.

Correlation between AAT-A3F and clinicopathological parameters.

r P value
Age (Yr) 0.092 NS
BMI (kg/m2) 0.066 NS
Plt (104/μL) −0.172 NS
Albumin (g/dL) −0.252 <0.001
T-bil (mg/dL) 0.071 NS
AST (IU/L) 0.196 NS
ALT (IU/L) −0.019 NS
ChE (U/L) −0.284 <0.001
γ-GTP (IU/L) 0.165 NS
AFP (ng/mL) 0.188 NS
TG (mg/dL) −0.113 <0.05
LDL-C (mg/dL) 0.087 NS
HDL-C (mg/dL) −0.136 NS
HbA1c (%) 0.035 NS
FBS (mg/dL) 0.009 NS
IRI (μIU/L) 0.178 NS
HOMA-IR 0.130 NS
cCK18 (U/L) 0.121 NS
M2BPGi (COI) 0.415 <0.001
FIB4 index 0.268 <0.01
APRI 0.236 NS
Pathological findings
Steatosis (0/1/2/3) −0.012 NS
Lobular inflammation (0/1/2/3) 0.314 <0.01
Ballooning (0/1/2) 0.285 <0.01
Fibrosis (0/1/2/3/4) 0.292 <0.001

The relationship between AAT-A3F and clinicopathological parameters was analysed using Spearman’s R correlations.